Literature DB >> 3143661

Galactosialidosis: molecular heterogeneity in biosynthesis and processing of protective protein for beta-galactosidase.

E Nanba1, A Tsuji, K Omura, Y Suzuki.   

Abstract

Biosynthesis and processing of the protective protein for beta-galactosidase in normal and galactosialidosis fibroblasts were investigated using specific antiserum preparations. A 45-kd precursor was processed to a mature 30-kd protein in normal fibroblasts. The mature protective protein was not detected in any of the twelve galactosialidosis fibroblast strains examined in this study. The precursor was not detected in two cases and in the others was of heterogeneous molecular weight, i.e., normal, abnormally low, or abnormally high. These molecular abnormalities were not correlated with clinical manifestations of the patients.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3143661     DOI: 10.1007/bf00273645

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  18 in total

1.  Macular cherry-red spots and myoclonus with dementia: coexistent neuraminidase and beta-galactosidase deficiencies.

Authors:  D A Wenger; T J Tarby; C Wharton
Journal:  Biochem Biophys Res Commun       Date:  1978-05-30       Impact factor: 3.575

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Biosynthesis of lysosomal enzymes in fibroblasts. Synthesis as precursors of higher molecular weight.

Authors:  A Hasilik; E F Neufeld
Journal:  J Biol Chem       Date:  1980-05-25       Impact factor: 5.157

4.  Prenatal diagnosis of sialidosis with combined neuraminidase and beta-galactosidase deficiency.

Authors:  W J Kleijer; A Hoogeveen; F W Verheijen; M F Niermeijer; H Galjaard; J S O'Brien; T G Warner
Journal:  Clin Genet       Date:  1979-07       Impact factor: 4.438

5.  Macular cherry-red spot, corneal clouding, and beta-galactosidase deficiency. Clinical, biochemical, and electron microscopic study of a new autosomal recessive storage disease.

Authors:  M F Goldberg; E Cotlier; L G Fichenscher; K Kenyon; R Enat; S A Borowsky
Journal:  Arch Intern Med       Date:  1971-09

6.  Galactosialidosis: a direct evidence that a 46-kilodalton protein restores deficient enzyme activities in fibroblasts.

Authors:  E Nanba; A Tsuji; K Omura; Y Suzuki
Journal:  Biochem Biophys Res Commun       Date:  1987-04-14       Impact factor: 3.575

7.  The relation between human lysosomal beta-galactosidase and its protective protein.

Authors:  A T Hoogeveen; F W Verheijen; H Galjaard
Journal:  J Biol Chem       Date:  1983-10-25       Impact factor: 5.157

8.  Beta-galactosidase-neuraminidase deficiency: restoration of beta-galactosidase activity by protease inhibitors.

Authors:  Y Suzuki; H Sakuraba; K Hayashi; K Suzuki; K Imahori
Journal:  J Biochem       Date:  1981-07       Impact factor: 3.387

9.  Human placental neuraminidase. Activation, stabilization and association with beta-galactosidase and its protective protein.

Authors:  F W Verheijen; S Palmeri; A T Hoogeveen; H Galjaard
Journal:  Eur J Biochem       Date:  1985-06-03

10.  [Two siblings with beta-galactosidase-neuraminidase deficiency (galactosialidosis) developing clinical symptoms in early childhood].

Authors:  E Takeda; Y Kuroda; T Tomita; H Kobashi; M Ito; T Watanabe; K Toshima; T Hashimoto; M Miyao
Journal:  No To Hattatsu       Date:  1984-09
View more
  1 in total

1.  Beta-galactosidase-deficient human fibroblasts: uptake and processing of the exogenous precursor enzyme expressed by stable transformant COS cells.

Authors:  A Oshima; K Itoh; Y Nagao; H Sakuraba; Y Suzuki
Journal:  Hum Genet       Date:  1990-10       Impact factor: 4.132

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.